Dual inhibition of p38α MAPK and Casein kinase δ/ϵ as a novel treatment strategy for AR-independent and…

The future of brain tumor treatment: integrating platelet-based liquid biopsy, advanced drug delivery systems, and eicosanoid inhibition
Sara Di Berardino, Marta Zarà, Huzaifa Ali Ahfaz +2
Frontiers in pharmacology1 Oct 2026Peer-reviewedCC BYFull textHuman geneticsEurope PMCCrossref
A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis
Francesca Conradie, Tasnim Badat, Asanda Poswa +9
New England Journal of Medicine24 Jun 2026Peer-reviewedLicence not statedFull text29 citedInfectious diseaseOpenAlex
566 OBX-115 TIL cell therapy in ICI-resistant advanced melanoma: pooled safety and updated efficacy with minimally invasive tumor tissue procurement, low-dose lymphodepletion, and IL2-free regimen
Michael Davies, Yazan Samhouri, Omid Hamid +15
Journal for ImmunoTherapy of Cancer7 Nov 2026Peer-reviewedCC BYFull textOncologyDOAJ
Revisiting AXL as a therapeutic target in soft tissue sarcoma: dubermatinib and bemcentinib effects are largely independent of AXL inhibition
C. Garnes-Garcia, P. Fernandez-Aroca, F. J. Cimas +7
bioRxiv2 Oct 2026PreprintCC BY-NCFull textOncologybioRxiv
Baseline serum carcinoembryonic antigen (CEA) is an independent prognostic biomarker for metastatic castration-resistant prostate cancer (mCRPC) patients receiving 177Lu-PSMA therapy
Emilio Francesco Giunta, Irene Marini, Ilaria Grassi +11
European Journal of Nuclear Medicine and Molecular Imaging11 Sep 2026Peer-reviewedCC BY-NC-ND 4.0Full textMedical imaging & radiologyPMC

Cite

BibTeX

@misc{chakravarti2026dual,
  title = {{Dual inhibition of p38α MAPK and Casein kinase δ/ϵ as a novel treatment strategy for AR-independent and taxane-resistant advanced prostate cancer}},
  author = {S. Chakravarti and S. Mazumder and F. Hemmati and F. Amiri and S. Batten and P. Mistriotis and R. Arnold and U. K. Mukherjee and T. Mitra Ghosh and A. K. Mitra},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.29.754128},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.29.754128v1},
}

RIS

TY  - UNPB
TI  - Dual inhibition of p38α MAPK and Casein kinase δ/ϵ as a novel treatment strategy for AR-independent and taxane-resistant advanced prostate cancer
AU  - S. Chakravarti
AU  - S. Mazumder
AU  - F. Hemmati
AU  - F. Amiri
AU  - S. Batten
AU  - P. Mistriotis
AU  - R. Arnold
AU  - U. K. Mukherjee
AU  - T. Mitra Ghosh
AU  - A. K. Mitra
PY  - 2026
DA  - 2026/09/29
PB  - bioRxiv
DO  - 10.64898/2026.09.29.754128
UR  - https://www.biorxiv.org/content/10.64898/2026.09.29.754128v1
ER  -

Related

Cite